Multiple primary malignant neoplasms: Case report and a comprehensive review of the literatureDEMANDANTE, Carlo Greg N; TROYER, Dean A; MILES, Toni P et al.American journal of clinical oncology. 2003, Vol 26, Num 1, pp 79-83, issn 0277-3732, 5 p.Article

Expression profiling identifies a novel α-methylacyl-CoA racemase exon with fumarate hydratase homologySHEN-ONG, Grace L; YUN FENG; TROYER, Dean A et al.Cancer research (Baltimore). 2003, Vol 63, Num 12, pp 3296-3301, issn 0008-5472, 6 p.Article

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and akt activationBEDOLLA, Roble; PRIHODA, Thomas J; KREISBERG, Jeffrey I et al.Clinical cancer research. 2007, Vol 13, Num 13, pp 3860-3867, issn 1078-0432, 8 p.Article

Differential effects of p21^WAF1/CIP1 deficiency on MMTV-ras and MMTV-myc mammary tumor propertiesBEARSS, David J; LEE, Richard J; TROYER, Dean A et al.Cancer research (Baltimore). 2002, Vol 62, Num 7, pp 2077-2084, issn 0008-5472Article

Association of Polymorphisms in TGFB1 and Prostate Cancer PrognosisBRAND, Timothy C; BERMEJO, Carlos; CANBY-HAGINO, Edith et al.The Journal of urology. 2008, Vol 179, Num 2, pp 754-758, issn 0022-5347, 5 p.Article

Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridizationVIJAYAKUMAR, Sapna; HALL, Devon C; REVELES, Xavier T et al.Cancer research (Baltimore). 2006, Vol 66, Num 8, pp 4055-4064, issn 0008-5472, 10 p.Article

External validation of the prostate cancer prevention trial risk calculator in a screened populationPAREKH, Dipen J; ANKERST, Donna Pauler; HIGGINS, Betsy A et al.Urology (Ridgewood, NJ). 2006, Vol 68, Num 6, pp 1152-1155, issn 0090-4295, 4 p.Article

Phosphorylation of Akt (Ser⁴⁷³) is an excellent predictor of poor clinical outcome in prostate cancerKREISBERG, Jeffrey I; MALIK, Shazli N; PRIHODA, Thomas J et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5232-5236, issn 0008-5472, 5 p.Article

Nonhuman Primates as Models for Studies of Prostate Specific Antigen and Prostatic DiseasesMUBIRU, James N; HUBBARD, Gene B; DICK, Edward J et al.The Prostate. 2008, Vol 68, Num 14, pp 1546-1554, issn 0270-4137, 9 p.Article

Association of RNASEL variants with prostate cancer risk in hispanic caucasians and african americansSHOOK, Stacie J; BEUTEN, Joke; TORKKO, Kathleen C et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5959-5964, issn 1078-0432, 6 p.Article

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancerMALIK, Shazli N; BRATTAIN, Michael; GHOSH, Paramita M et al.Clinical cancer research. 2002, Vol 8, Num 4, pp 1168-1171, issn 1078-0432Article

Involvement of FLIP in 2-Methoxyestradiol-Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate ModelGANAPATHY, Manonmani; GHOSH, Rita; XIEJIANPING et al.Clinical cancer research (Print). 2009, Vol 15, Num 5, pp 1601-1611, issn 1078-0432, 11 p.Article

Semaphorin 3B and 3F Single Nucleotide Polymorphisms are Associated With Prostate Cancer Risk and Poor PrognosisBEUTEN, Joke; GARCIA, Dawn; LEACHT, Robin J et al.The Journal of urology. 2009, Vol 182, Num 4, pp 1614-1620, issn 0022-5347, 7 p., 1Article

Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mLCANBY-HAGINO, Edith; HERNANDEZ, Javier; BRAND, Timothy C et al.Urology (Ridgewood, NJ). 2007, Vol 70, Num 4, pp 748-752, issn 0090-4295, 5 p.Article

The modulation of prostate cancer risk with α-tocopherol : A pilot randomized, controlled clinical trialHERNANDEZ, Javier; SYED, Samira; WEISS, Geoffrey et al.The Journal of urology. 2005, Vol 174, Num 2, pp 519-522, issn 0022-5347, 4 p.Article

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic menBALIC, Ivana; GRAHAM, Stanley T; TROYER, Dean A et al.The Journal of urology. 2002, Vol 168, Num 5, pp 2245-2248, issn 0022-5347Article